AAAAAA

   
Results: 1-14 |
Results: 14
Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli
Authors: Chen, B Stiff, P Sloan, G Kash, J Manjunath, R Pathasarathy, M Oldenburg, D Foreman, KE Nickoloff, BJ
Citation: B. Chen et al., Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli, CLIN IMMUNO, 98(2), 2001, pp. 280-292
Double-blind comparative trial of oral ondansetron versus oral granisetronversus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation
Authors: Fox-Geiman, MP Fisher, SG Kiley, K Fletcher-Gonzalez, D Porter, N Stiff, P
Citation: Mp. Fox-geiman et al., Double-blind comparative trial of oral ondansetron versus oral granisetronversus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation, BIOL BLOOD, 7(11), 2001, pp. 596-603
Pilot trial of interleukin-1 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: Expansion of immune effectors within the stem-cell graft and post-stem-cell infusion
Authors: Sosman, JA Stiff, P Moss, SM Sorokin, P Martone, B Bayer, R van Besien, K Devine, S Stock, W Peace, D Chen, Y Long, C Gustin, D Viana, M Hoffman, R
Citation: Ja. Sosman et al., Pilot trial of interleukin-1 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: Expansion of immune effectors within the stem-cell graft and post-stem-cell infusion, J CL ONCOL, 19(3), 2001, pp. 634-644
Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial
Authors: Stewart, AK Vescio, R Schiller, G Ballester, O Noga, S Rugo, H Freytes, C Stadtmauer, E Tarantolo, S Sahebi, F Stiff, P Meharchard, J Schlossman, R Brown, R Tully, H Benyunes, M Jacobs, C Berenson, R White, M DiPersio, J Anderson, KC Berenson, J
Citation: Ak. Stewart et al., Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial, J CL ONCOL, 19(17), 2001, pp. 3771-3779
A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation
Authors: Pecora, AL Stiff, P LeMaistre, CF Bayer, R Bachier, C Goldberg, SL Parthasarathy, M Jennis, AA Smith, AK Douville, J Chen, B Armstrong, RD Mandalam, RK Preti, R
Citation: Al. Pecora et al., A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation, BONE MAR TR, 28(3), 2001, pp. 295-303
Mucositis associated with stem cell transplantation: current status and innovative approaches to management
Authors: Stiff, P
Citation: P. Stiff, Mucositis associated with stem cell transplantation: current status and innovative approaches to management, BONE MAR TR, 27, 2001, pp. S3-S11
A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma
Authors: Stiff, P Gingrich, R Luger, S Wyres, MR Brown, RA LeMaistre, CF Perry, J Schenkein, DP List, A Mason, JR Bensinger, W Wheeler, C Freter, C Parker, WRL Emmanouilides, C
Citation: P. Stiff et al., A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma, BONE MAR TR, 26(5), 2000, pp. 471-481
Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulatedunrelated umbilical cord blood
Authors: Pecora, AL Stiff, P Jennis, A Goldberg, S Rosenbluth, R Price, P Goltry, KL Douville, J Armstrong, RD Smith, AK Preti, RA
Citation: Al. Pecora et al., Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulatedunrelated umbilical cord blood, BONE MAR TR, 25(7), 2000, pp. 797-799
A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients
Authors: List, AF Maziarz, R Stiff, P Jansen, J Liesveld, J Andrews, F Schuster, M Wolff, S Litzow, M Karanes, C Dahlberg, S Kirkhart, B Bianco, JA Singer, JW
Citation: Af. List et al., A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients, BONE MAR TR, 25(3), 2000, pp. 283-291
Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograftproducts from multiple myeloma patients
Authors: Vescio, RA Wu, CH Zheng, L Sheen, D Ma, H Liu, J Stewart, AK Ballester, O Noga, SJ Rugo, H Freytes, C Stadtmauer, E Sahebi, F Tarantolo, S Stiff, P Schiller, GJ White, M Jacobs, C DiPersio, J Anderson, KC Berenson, JR
Citation: Ra. Vescio et al., Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograftproducts from multiple myeloma patients, BONE MAR TR, 25(2), 2000, pp. 153-160
Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer
Authors: Stiff, P Chen, BH Franklin, W Oldenberg, D Hsi, E Bayer, R Shpall, E Douville, J Mandalam, R Malhotra, D Muller, T Armstrong, RD Smith, A
Citation: P. Stiff et al., Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer, BLOOD, 95(6), 2000, pp. 2169-2174
Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34(+) cells
Authors: Krieger, MS Schiller, G Berenson, JR Stewart, K Noga, SJ Ballester, O Tarantolo, S Stiff, P Kuhn, D Scherzo, E Sing, A Jacobs, C White, JM DiPersio, J
Citation: Ms. Krieger et al., Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34(+) cells, BONE MAR TR, 24(1), 1999, pp. 25-28
Multicenter phase III trial to evaluate CD34(+) selected versus unselectedautologous peripheral blood progenitor cell transplantation in multiple myeloma
Authors: Vescio, R Schiller, G Stewart, AK Ballester, O Noga, S Rugo, H Freytes, C Stadtmauer, E Tarantolo, S Sahebi, F Stiff, P Meharchard, J Schlossman, R Brown, R Tully, H Benyunes, M Jacobs, C Berenson, R DiPersio, J Anderson, K Berenson, J
Citation: R. Vescio et al., Multicenter phase III trial to evaluate CD34(+) selected versus unselectedautologous peripheral blood progenitor cell transplantation in multiple myeloma, BLOOD, 93(6), 1999, pp. 1858-1868
Working readers: A reply to Audrey Thompson
Authors: Stiff, P
Citation: P. Stiff, Working readers: A reply to Audrey Thompson, J SCHOLAR P, 29(4), 1998, pp. 219-226
Risultati: 1-14 |